You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

failed temodar

Showing 1 - 25 of 2,624
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer Trial in Los Angeles (temozolomide)

Completed
  • Metastatic Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +11 more
Aug 15, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Soft Tissue Sarcoma Adult Trial (Surufatinib)

Not yet recruiting
  • Soft Tissue Sarcoma Adult
  • (no location specified)
Oct 29, 2023

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • CNS Progression
  • Temozolomide plus Osimertinib
  • Temozolomide plus Lorlatinib
  • Aurora, Colorado
    University of Colorado Hospital
May 12, 2022

Ovarian Aging in Low Grade Glioma Treated With Temozolomide

Terminated
Has Results
  • Low Grade Glioma
    • San Francisco, California
      UCSF Center for Reproductive Health
    Jul 6, 2022

    Acute Ischemic Stroke Trial in Beijing (Bailout angioplasty, thrombectomy alone)

    Recruiting
    • Acute Ischemic Stroke
    • Bailout angioplasty
    • thrombectomy alone
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Oct 31, 2022

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab

    Recruiting
    • Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
    • Cadonilimab Injection
    • Ramucirumab Injection
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital Airport Hospital
    May 14, 2023

    Breast Cancer, Breast Tumor, Breast Cancer Stage IV Trial in San Juan (MBQ-167)

    Recruiting
    • Breast Cancer
    • +2 more
    • San Juan, Puerto Rico
      FDI Clinical Research
    Oct 4, 2023

    Breast Cancer Trial in China (JSKN003, Capecitabine tablets, Gemcitabine HCl for injection)

    Not yet recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
    • +49 more
    Oct 6, 2023

    Glaucoma Trial in Cincinnati (iStent Infinite)

    Recruiting
    • Glaucoma
    • iStent Infinite
    • Cincinnati, Ohio
      Glaukos Investigator Site
    Sep 26, 2023

    Solid Tumors Trial in Guangzhou (MASCT-I injection)

    Completed
    • Solid Tumors
    • MASCT-I injection
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 25, 2023

    Soft Tissue Sarcoma Trial (Candonilimab)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • (no location specified)
    Jun 22, 2023

    Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Anlotinib and TQB2450
    • Shanghai, Shanghai, China
      Zhongshan hospital
    Sep 4, 2023

    Cholangiocarcinoma Metastatic Trial in China (TT-00420 (tinengotinib))

    Not yet recruiting
    • Cholangiocarcinoma Metastatic
    • TT-00420 (tinengotinib)
    • Guangzhou, Guangdong, China
    • +6 more
    Sep 26, 2023

    Cervical Cancer Trial in China (Disitamab Vedotin, Zimberelimab)

    Not yet recruiting
    • Cervical Cancer
    • Bengbu, Anhui, China
    • +11 more
    Nov 23, 2023

    Colorectal Cancer, Chinese Herbal Medicine, Progression-free Survival Trial in China (Brucea javanica oil emulsion injection,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Brucea javanica oil emulsion injection
    • The best supportive treatment
    • Guangzhou, Guangdong, China
    • +3 more
    Jun 1, 2023

    Systemic Lupus Erythematosus, Lupus Erythematosus Trial in San Leandro, DeBary, Houston (Imvotamab)

    Recruiting
    • Systemic Lupus Erythematosus
    • Lupus Erythematosus
    • San Leandro, California
    • +2 more
    Sep 19, 2023

    Advanced Solid Tumor Trial in Shanghai (HS-10386)

    Recruiting
    • Advanced Solid Tumor
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Jun 20, 2023

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022